ChatDocto
Find a doctor
White scored tablet

PANADOL EXTRA 500 mg/65 mg

Paracetamol + Cafeine · scored film-coated tablets

B/8Oral use
See all pack prices
Strength500 mg/65 mg
Therapeutic classSYSTEME NERVEUX
ATC codeN02BE51

About this medicine

PANADOL EXTRA 500 mg/65 mg scored film-coated tablets is listed in Tunisia's medicine catalog under the active ingredient Paracetamol + Cafeine. This page brings together its recorded pack formats, prices and CNAM coverage information.

What is this medicine used for?

Review pending

A reviewed explanation of uses is not yet published for this medicine in this language. Ask a pharmacist for the leaflet for your exact product.

What side effects should I know about?

Review pending

A reviewed side-effect guide is not yet published for this medicine in this language. This does not mean that the medicine has no side effects. Read your product leaflet or ask a pharmacist.

Price by pack

Compare the recorded price for each exact pack. A catalog entry does not confirm pharmacy stock.

  • Pack · B/8

    8 units in this pack

    Price source not confirmed1,050 DT
    AMM No.
    9253202
    CNAM reference amount
    CNAM status to be confirmed

    Price source: No verified price source is linked to this pack.

    Price effective date not provided

This reference amount is not a guaranteed refund or a personal out-of-pocket estimate. Your coverage conditions must be confirmed separately.

Medicine details

Dosage formscored film-coated tablets
Route of administrationOral use
LaboratoryTERIAK
OriginOriginator
ScheduleO
ATC codeN02BE51 — Paracétamol, associations excluant les psycholeptiques
Therapeutic classSYSTEME NERVEUX

Medicines with matching catalog characteristics

These entries match the recorded ingredient, strength, form and route. This does not establish that they can replace your medicine; confirm any change with a pharmacist.

ALGESIC EXTRA 500 mg/65 mgComprimés pelliculés sécablesDAR-ESSAYDALI. · B/16
Recorded public price3,205 DT

Price source: CNAM — Liste des médicaments remboursables · 2026-08-04

Source recorded: August 23, 2026